rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
3
|
pubmed:dateCreated |
1996-11-19
|
pubmed:abstractText |
The protein A immunoadsorption column is a new treatment for immune thrombocytopenic purpura (ITP). We used a decision-analytic approach with a Markov process to model the cost effectiveness of this treatment compared with splenectomy for steroid-resistant ITP patients. Data informing the model were obtained from published literature, a panel of physicians, and public databases. We found initial treatment with the protein A immunoadsorption column to be less expensive and more effective than initial treatment with splenectomy.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:issn |
0266-4623
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
12
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
436-49
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:8840664-Adrenal Cortex Hormones,
pubmed-meshheading:8840664-Adult,
pubmed-meshheading:8840664-Combined Modality Therapy,
pubmed-meshheading:8840664-Cost-Benefit Analysis,
pubmed-meshheading:8840664-Decision Support Techniques,
pubmed-meshheading:8840664-Drug Resistance,
pubmed-meshheading:8840664-Health Care Costs,
pubmed-meshheading:8840664-Humans,
pubmed-meshheading:8840664-Immunosorbent Techniques,
pubmed-meshheading:8840664-Markov Chains,
pubmed-meshheading:8840664-Models, Economic,
pubmed-meshheading:8840664-Purpura, Thrombocytopenic, Idiopathic,
pubmed-meshheading:8840664-Quality-Adjusted Life Years,
pubmed-meshheading:8840664-Splenectomy,
pubmed-meshheading:8840664-Staphylococcal Protein A
|
pubmed:year |
1996
|
pubmed:articleTitle |
Protein A immunoadsorption column versus splenectomy in the treatment of steroid-resistant immune thrombocytopenic purpura. A cost-effectiveness analysis.
|
pubmed:publicationType |
Journal Article,
Comparative Study
|